Showing 1301-1310 of 2192 results for "".
- Pain Managementhttps://practicalneurology.com/diseases-diagnoses/headache-pain/pn1008_10-pdf/30986/Choosing Between Short- and Long-Acting Opioids in Chronic Pain ManagementIn the realm of chronic pain management, selecting the appropriate opioid analgesic—whether short-acting or long-acting—remains a nuanced decision due to limited comparative data. Charles Argoff, MD, in his recent article for
- When and How to Discontinue AED Therapy in People with Epilepsyhttps://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/pn1007Epilepsy-pdf/31115/Discontinuation of Antiepileptic Drugs: Balancing Benefits and RisksAntiepileptic drugs (AEDs) have been the cornerstone of seizure disorder management for over seven decades, evolving from phenobarbital to more than two dozen agents. A critical question arises when patients achieve seizure freedom:
- Epilepsy Essentialshttps://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/PN0306epilepsy-pdf/31336/Non-epileptic psychogenic seizures (NES) present a significant diagnostic challenge in neurology due to their overlapping features with epileptic seizures. NES, previously termed pseudo-seizures, are now understood as manifestations of somatization or conversion disorders, where psychological trauma
- Achieving Freedom From AEDs Without Compromising Controlhttps://practicalneurology.com/columns/practice-management/achieving-freedom-from-aeds-without-compromising-control/31393/Tapering Antiepileptic Drugs: Balancing Seizure Control and Quality of LifeIn the October 2005 issue of *Practical Neurology*, Dr. Christopher Skidmore explores whether epilepsy necessitates lifelong antiepileptic drug (AED) therapy. Highlighting the dual objectives of achieving seizure control whil
- Dementia Insightshttps://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/PN1005DementiaInsights-pdf/31386/Medicare’s Limited Approval of PET Scans in Dementia: Implications for Clinical PracticeIn September 2004, the Centers for Medicare and Medicaid Services (CMS) approved the use of positron emission tomography (PET) scans for dementia diagnosis, specifically to differentiate Alzheimer’s disease (AD)
- Dementia Insightshttps://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/PN0705dementia-pdf/31426/
- Income Survey: Staying Ahead of the Curvehttps://practicalneurology.com/columns/practice-management/income-survey-staying-ahead-of-the-curve/31454/Financial Trends and Strategies for Neurology Practices: Insights from Practical Neurology May 2005The May 2005 issue of Practical Neurology, under the guidance of Editor-in-Chief Jack Persico, delves into the financial dynamics affecting neurology practices. Despite a rise in neurology billings in
- Bringing Chronic Daily Headache Into Focushttps://practicalneurology.com/diseases-diagnoses/headache-pain/PN0305FeaChronicHeadache-pdf/31481/Updates to IHS Headache Classification: Implications for Clinical PracticeThe International Headache Society (IHS) recently updated its classification of chronic daily headache (CDH), presenting significant changes that impact neurologists and headache specialists. Published in *Cephalalgia* in 2004
Multiple Sclerosis: Putting the Revised McDonald Criteria Into Practice
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/multiple-sclerosis-putting-the-revised-mcdonald-criteria-into-practice/54606/The Best and Worst of Times?
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/the-best-and-worst-of-times/30206/Despite exciting advances in diagnosis and myriad treatments, clinical management for patients with multiple sclerosis remains challenging.